Allogenic Blood Transfusion is Associated with Poor Perioperative and Long-Term Outcome in Esophageal Cancer

[1]  He Huang,et al.  Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer. , 2014, The Annals of thoracic surgery.

[2]  U. Hopt,et al.  Improved Long-Term Survival After Esophagectomy for Esophageal Cancer: Influence of Epidemiologic Shift and Neoadjuvant Therapy , 2013, Journal of Gastrointestinal Surgery.

[3]  Mohit Bhandari,et al.  Operative blood loss, blood transfusion and 30-day mortality in older patients after major noncardiac surgery. , 2012, Canadian journal of surgery. Journal canadien de chirurgie.

[4]  M. Sakurada,et al.  Intraoperative Blood Transfusion Contributes to Decreased Long-Term Survival of Patients With Esophageal Cancer , 2012, World Journal of Surgery.

[5]  K. Delman,et al.  Effects of Perioperative Red Blood Cell Transfusion on Disease Recurrence and Survival After Pancreaticoduodenectomy for Ductal Adenocarcinoma , 2011, Annals of Surgical Oncology.

[6]  J. Vincent,et al.  Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. , 2010, JAMA.

[7]  D. Gerber.  Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer , 2010 .

[8]  J. Carson,et al.  Anemia in the preoperative patient. , 2009, The Medical clinics of North America.

[9]  J. Vauthey,et al.  Blood loss in surgical oncology: Neglected quality indicator? , 2009, Journal of surgical oncology.

[10]  Wiley Interscience,et al.  Volume‐ or outcome‐based referral to improve quality of care for esophageal cancer surgery in The Netherlands , 2009, Journal of surgical oncology.

[11]  D. Holmes,et al.  Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. , 2009, Journal of the American College of Cardiology.

[12]  T. B. Vaughan,et al.  Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. , 2009, Journal of the American College of Surgeons.

[13]  J. Mcloughlin,et al.  Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. , 2008, The Journal of surgical research.

[14]  M. McCarter,et al.  Stored red blood cell transfusion induces regulatory T cells. , 2009, Journal of the American College of Surgeons.

[15]  P. Schneider,et al.  Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer , 2009, Journal of Gastrointestinal Surgery.

[16]  J. Cerhan,et al.  Blood transfusion, anesthesia, surgery and risk of non‐Hodgkin lymphoma in a population‐based case–control study , 2008, International journal of cancer.

[17]  S. Kitano,et al.  Prognosis and postoperative lymphocyte count in patients with hepatocellular carcinoma who received intraoperative allogenic blood transfusion: a retrospective study. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  J. Luketich,et al.  Resection for esophageal cancer: strategies for optimal management. , 2008, The Annals of thoracic surgery.

[19]  D. Wijeysundera,et al.  Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study , 2008, Circulation.

[20]  Chris A Rogers,et al.  Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery , 2007, Circulation.

[21]  E. Berthelet,et al.  Prognostic Significance of Blood Transfusions in Patients With Esophageal Cancer Treated With Combined Chemoradiotherapy , 2007, American journal of clinical oncology.

[22]  I. C. Tudor,et al.  Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery , 2007, Circulation.

[23]  B. Coiffier,et al.  Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option , 2007, Current medical research and opinion.

[24]  Facs Randal S. Weber MD,et al.  Anemia and Transfusions in Patients Undergoing Surgery for Cancer , 2007, Annals of Surgical Oncology.

[25]  G. Dionigi,et al.  Postoperative infections after oesophageal resections: the role of blood transfusions , 2006, World journal of surgical oncology.

[26]  Jeffrey L Carson,et al.  Detection, Evaluation, and Management of Anemia in the Elective Surgical Patient , 2005, Anesthesia and analgesia.

[27]  H. Osugi,et al.  Effect of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. , 2005, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[28]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[29]  S. Motoyama,et al.  Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease‐free survival among patients with recurrent esophageal cancer , 2004, Journal of surgical oncology.

[30]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[31]  H. Saeki,et al.  Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma , 2001, Cancer.

[32]  Y. Kajiyama,et al.  Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. , 2000, Surgery.

[33]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[34]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[35]  P. Terasaki,et al.  Improvement of kidney-graft survival with increased numbers of blood transfusions. , 1978, The New England journal of medicine.